Concern and continuity in the care of cancer patients and their carers: development of the intervention

ISRCTN ISRCTN43339432
DOI https://doi.org/10.1186/ISRCTN43339432
Protocol serial number SDO/13/2001 (e)
Sponsor University College London (UK)
Funder NHS Service and Delivery Organisation (UK) [ref: SDO/13/2001 (e)]
Submission date
13/09/2005
Registration date
17/10/2005
Last edited
10/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

http://cancerhelp.cancerresearchuk.org/trials/a-study-looking-at-the-continuity-of-care-of-patients-with-cancer

Contact information

Prof Michael King
Scientific

Dept Mental Health Sciences
Royal Free and University College Medical School
Rowland Hill Street
London
NW3 2PF
United Kingdom

Phone +44 (0)20 7794 0500
Email m.king@medsch.ucl.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study objectivesThat the development and testing of a complex intervention will lead to improved continuity of care in cancer for patients and those close to them by the delivery of the planned intervention.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedContinuity of care in cancer
InterventionA feasibility (phase II) randomised trial in which we are developing and testing a new intervention - this will be a form of care record for teams in which aspects of continuity of care for each patient will be assessed.
ECAP - engagement and continuity action plan: a continuity of care risk assessment completed by secondary care workers at multi-disciplinary meeting.
Intervention typeOther
Primary outcome measure(s)

1. Acceptability
2. Practicality and feasibility of ECAP
3. Improved patient experience of engagement with care

Key secondary outcome measure(s)

1. Economic benefits
2. Patient and nominated friend/family member well being

Completion date30/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration80
Key inclusion criteria1. Aged over 18 years
2. Able to give informed consent
3. Patients diagnosed with breast, lung or colorectal cancer, or their nominated relative or friend
Key exclusion criteria1. Unable to give informed consent
2. Aged under 18 years
Date of first enrolment01/04/2006
Date of final enrolment30/09/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Dept Mental Health Sciences
London
NW3 2PF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 27/01/2009 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes